MP591COST-MINIMISATION ANALYSIS OF SUCROFERRIC OXYHYDROXIDE AND SEVELAMER CARBONATE IN PATIENTS ON DIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN THE UNITED KINGDOM | Zendy

AI Assistant Blog Pricing

MP591COST-MINIMISATION ANALYSIS OF SUCROFERRIC OXYHYDROXIDE AND SEVELAMER CARBONATE IN PATIENTS ON DIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN THE UNITED KINGDOM

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.